Drawing for UNLOCK THE POWER OF YOUR CLINICAL DATA

USPTO serial 97062239

UNLOCK THE POWER OF YOUR CLINICAL DATA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
REGAN, JOHN B
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with UNLOCK THE POWER OF YOUR CLINICAL DATA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew Saunders

MATTHEW SAUNDERS SAUNDERS & SILVERSTEIN LLP14 CEDAR STREET SUITE 224AMESBURY, MA 01913UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035consulting in the fields of healthcare operations management and hospital operations management; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare data for business purposes; business services provided to the healthcare industry, namely, core measure abstraction services in the nature of extracting and summarizing information from medical records, and registry abstraction services in the nature of extracting and summarizing information from medical records; statistical analysis for business purposes, namely, review of hospital mortality statistics; providing independent reviews of other businesses for commercial purposes, namely, peer review of medical services and peer review of complaints by recipients regarding the quality of medical care received; statistical analysis and reporting of data for business purpose, namely, for use in infection control and prevention services, in patient readmission reduction services, and in quality surveillance services, namely, collection, reporting, and analysis of healthcare quality data for business purposes; business-risk assessment services provided to the healthcare industry, namely, assessment and prediction of patient readmission riskACTIVE—
041Regulatory compliance training services in the field of healthcareACTIVE—
042Software as a service (SAAS) services featuring software for use in healthcare data abstraction; Software as a service (SAAS) services featuring software for use in the collection, compilation, abstraction, analysis, and reporting of healthcare data; Software as a service (SAAS) services featuring software for use in time tracking and workflow management of healthcare personnel; Software as a service (SAAS) services featuring software for use by hospitals and health care providers in the collection, compilation, and analysis of healthcare quality performance data and key performance metrics; Software as a service (SAAS) services featuring software enabling hospitals and health care providers to submit healthcare quality performance data to third parties for business purposesACTIVE—
044medical consulting services in the field of disease infection control; medical consulting services in the field of infection screening, control, and prevention; medical consulting services to health care providers in the field of the detection and prevention of healthcare-associated infections; medical consultancy, namely, review of hospital mortality causesACTIVE—
045Regulatory compliance consulting in the field of healthcare; Providing information and advice regarding regulatory compliance in the field of healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 5, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 5, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 1, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 6, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 6, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jul 11, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 11, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 11, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 5, 2022DOCKASSIGNED TO EXAMINER—
Oct 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance